Skip to content
Suraksha Diagnostic logo

Suraksha Diagnostic IPO

MainboardListedPharma & Healthcare
Check allotment status
Issue price
₹441
Listing price
₹438
-0.68%
Current price
₹341.7
-22.52%
Subscribed
1.27x
Issue size
₹846.25 Cr
Listed on
6 Dec 2024

IPO timeline

  1. Opens
    29 NovFri
  2. Closes
    3 DecTue
  3. Allotment
    4 DecWed
  4. Refunds
    5 DecThu
  5. Demat credit
    5 DecThu
  6. Listing
    6 DecFri

Issue details

Price band
₹420 – ₹441 per share
Issue size
₹846.25 Cr
Fresh issue
None
Offer for sale
₹846.25 Cr
Issue type
OFS only
Face value
₹2 per share
Lot size
34 shares
Minimum investment
₹14,994
Listing on
BSE, NSE
Exchange code
SURAKSHA · 544293

Lot size and investment

ApplicationLotsSharesAmount
Retail (Min)134₹14,994
Retail (Max)13442₹1,94,922
S-HNI (Min)14476₹2,09,916
B-HNI (Min)672,278₹10,04,598

Reservation

QIB
95,94,664 shares (50.00% of the Offer)
NII
28,78,400 shares (15.00% of the Offer)
Retail
67,16,266 shares (35.00% of the Offer)

Allotment status

Registrar: KFin Technologies Limited

The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).

Check allotment on KFin Technologies
  1. 1Open the registrar's allotment page and select this IPO from the list.
  2. 2Enter your PAN, application number or DP / Client ID.
  3. 3Submit to see the number of shares allotted, if any.
Basis of allotment
4 Dec 2024
Refunds initiated
5 Dec 2024
Shares credited to demat
5 Dec 2024
Listing
6 Dec 2024

Grey market premium (GMP)

Updated 05 Dec 2024, 12:00 PM IST
Current GMP
₹12
+3.00%
Estimated listing price
₹453
Issue price ₹441
Highest
₹12
5 Dec
Lowest
₹10
4 Dec

GMP by day (₹ per share)

Day-wise GMP table
DateGMPPremiumEst. listing
5 Dec 2024₹12+3.00%₹453
4 Dec 2024₹10+2.00%₹451
Kostak rate
₹0

GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.

Subscription status

Updated 10 Nov 2026, 06:44 AM IST
Overall subscription
1.27x
Fully subscribed
  • QIB1.74x
  • NII (HNI)1.4x
  • Retail0.94x

Financials

Amounts in Rs. Crore
P/E (pre-issue)
74.89
P/E (post-issue)
74.89
EPS (₹)
5.89
RoE
14.09%
RoCE
21.46%
RoNW
14.09%
PAT Margin
10.57%
Debt / Equity
0.20
NAV (₹)
33.66

Pre-issue P/E uses the shares outstanding before the IPO; post-issue P/E includes the new shares. Calculated by Be IPO Ready at the issue price.

Period ended30 Jun 202431 Mar 202431 Mar 202331 Mar 2022
Assets314.20300.21281.20275.96
Total Income61.85222.26193.69225.77
Profit After Tax7.6723.136.0720.82
NET Worth187.05179.41155.93145.84
Reserves and Surplus176.80170.88147.40137.31
Total Borrowing7.578.6414.0119.03
CompanyIssue sizeP/ERoNWPAT marginSubscribedListing gain
Suraksha Diagnostic
This IPO
₹846.25 Cr74.8914.09%10.57%1.27x-0.68%
Ellenbarrie Industrial Gases
Mainboard · listed 1 Jul 2025
₹852.53 Cr67.6924.97%23.90%22.47x+21.50%
Nephrocare Health Services
Mainboard · listed 17 Dec 2025
₹871.05 Cr162.1913.19%8.88%13.96x+6.52%
Sudeep Pharma
Mainboard · listed 28 Nov 2025
₹895 Cr53.5527.88%27.63%93.72x+23.10%
Park Medi World
Mainboard · listed 17 Dec 2025
₹920 Cr63.5213.19%8.88%8.1x-1.98%
Molbio Diagnostics
Mainboard · listed 17 Aug 2026
₹939.7 Cr56.6714.55%11.28%70.26x+21.44%
Fusion CX
Mainboard · listed 22 Oct 2026
₹702 Cr18.739.12%11.36%4.45x+5.54%

Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.

About Suraksha Diagnostic

Suraksha Diagnostic Limited was incorporated as Suraksha Diagnostic Private Limited at Kolkata on 15 March 2005. It offers one-stop integrated pathology and radiology testing and medical consultation services. Its services include X-rays, ultrasonography, CT, MRI and vaccinations, through a central reference laboratory, 8 satellite laboratories and 215 customer touchpoints, including 49 diagnostic centres and 166 sample collection centres, as of 30 June 2024. Its promoters are Somnath Chatterjee, Ritu Mittal and Satish Kumar Verma. The IPO was Rs 846.25 crore and was entirely an offer for sale by the three promoters and investors, so the company received none of the money.

Strengths

  • Profit after tax rose from Rs 6.07 crore in FY2023 to Rs 23.13 crore in FY2024.
  • Borrowing was low at Rs 7.57 crore on 30 June 2024.
  • It runs 215 customer touchpoints across eastern India.
  • Net worth grew from Rs 145.84 crore on 31 March 2022 to Rs 187.05 crore on 30 June 2024.
  • The source puts return on net worth at 14.09%.

Risks

  • The whole Rs 846.25 crore issue was offer for sale, so no money went to the company.
  • The pre-issue P/E was 99.31 at the upper band of Rs 441, based on EPS of Rs 4.44.
  • Total income fell from Rs 225.77 crore in FY2022 to Rs 193.69 crore in FY2023, so growth has been uneven.
  • The business is concentrated in eastern India, with 49 diagnostic centres, and faces strong competition from national chains.
  • Promoters and the promoter group held 61.07% before the issue and 48.78% after it.

Promoters and shareholding

Somnath Chatterjee, Ritu Mittal and Satish Kumar Verma

Promoter holding, pre-issue
61.07%
Promoter holding, post-issue
48.78%

Registrar, lead managers and documents

Registrar

KFin Technologies Limited

040-79615565

sdl.ipo@kfintech.com

Company contact

91 33 66059750

investors@surakshanet.com

Suraksha Diagnostic IPO: common questions

1.When does the Suraksha Diagnostic IPO open and close?

The Suraksha Diagnostic IPO opens on 29 Nov 2024 and closes on 3 Dec 2024.

2.What is the price band of the Suraksha Diagnostic IPO?

The price band is ₹420 – ₹441 per share, with a lot size of 34 shares and a minimum investment of ₹14,994.

3.What is the size of the Suraksha Diagnostic IPO?

The issue size is ₹846.25 Cr (OFS only).

4.What is the GMP of the Suraksha Diagnostic IPO?

The last reported grey market premium is ₹12 per share as of 05 Dec 2024, 12:00 PM IST. GMP is unofficial and changes frequently.

5.When is the Suraksha Diagnostic IPO allotment?

The basis of allotment is expected on 4 Dec 2024. Allotment status can be checked with the registrar, KFin Technologies Limited.

6.When will the Suraksha Diagnostic IPO list?

The shares listed on 6 Dec 2024 on BSE, NSE.

7.Who is the lead manager of the Suraksha Diagnostic IPO?

The book running lead managers are Nuvama Wealth Management Ltd., SBI Capital Markets Ltd., ICICI Securities, and the registrar is KFin Technologies Limited.

8.How can my company launch an IPO like Suraksha Diagnostic?

Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.

For business owners

Your company could be the next listing

Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.

  • Eligibility check against NSE Emerge, BSE SME and Main Board norms
  • Indicative valuation and issue size for your business
  • A clear timeline from readiness to listing day

Check if your business can list

Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.

Prefer to talk? Call +91 92130 20393